27 Results for "

eIF4F

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "eIF4F" in MCE Product Catalog:

10
10 Cited Publications
Art. -Nr.: HY-112163
CAS. Nr.: 2098191-53-6
Reinheit:  99.69%
Synonyms: eFT226
Zotatifin (eFT226) is a potent, selective, and well-tolerated eIF4A inhibitor. Zotatifin promotes eIF4A binding to specific mRNA sequences with recognition motifs in the 5’-UTRs (IC50=2 nM) and interferes with the assembly of the eIF4F initiation complex . Zotatifin shows robust antiviral effects, it effectively reduces viral infectivity by inhibiting SARS-CoV-2 NP protein biogenesis (IC90=37 nM) . Zotatifin induces cell apoptosis .
3
3 Cited Publications
Art. -Nr.: HY-19560
CAS. Nr.: 2205871-61-8
Synonyms: SBI-756
Forschungsgebiete:  

Cancer

SBI-0640756 (SBI-756) is an inhibitor of eIF4G1 and disrupts the eIF4F complex.
Art. -Nr.: HY-148448
CAS. Nr.: 1402931-65-0
Reinheit:  99.81%
Forschungsgebiete:  

Cancer

eIF4A3-IN-9 is a Rocaglate analog. eIF4A3-IN-9 interferes with the assembly of the eIF4F translation complex, with EC50 values of 40 nM and > 2000 nM against myc-LUC and tub-LUC, respectively. eIF4A3-IN-9 can be used for the research of tumor pathogenesis .
Art. -Nr.: HY-148450
CAS. Nr.: 1402931-74-1
Forschungsgebiete:  

Cancer

eIF4A3-IN-16 (compound 60) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-16 inhibits MBA-MB-231cell growth with an EC50 value of 1 nM. eIF4A3-IN-16 interferes the assembling of eIF4F translation complex with a myc-LUC EC50 value of 1 nM and a tub-LUC EC50 value of 30 nM. eIF4A3-IN-16 can be used for triple negative breast cancer (TNBC) research .
Art. -Nr.: HY-148447
CAS. Nr.: 1402931-85-4
Reinheit:  99.92%
Forschungsgebiete:  

Cancer

eIF4A-IN-3, Silvestrol (HY-13251) analogue, is an eIF4A inhibitor. eIF4A-IN-3 blocks protein translation initiation by interfering with eIF4F complex assembly, preferentially inhibiting translation of mRNAs with long, highly structured 5'-untranslated regions. eIF4A-IN-3 inhibits proliferation of human breast cancer cells. eIF4A-IN-3 has moderate apical to basolateral permeability in intestinal cell monolayers and a low efflux ratio .
Art. -Nr.: HY-112163A
CAS. Nr.: 2098191-54-7
Reinheit:  97.32%
Synonyms: rel-eFT226
rel-Zotatifin is the racemic isomer of Zotatifin, acts as an eIF4A inhibitor with activity less than Zotatifin. Zotatifin (eFT226) is a potent, selective, and well-tolerated eIF4A inhibitor. Zotatifin promotes eIF4A binding to specific mRNA sequences with recognition motifs in the 5’-UTRs (IC50=2 nM) and interferes with the assembly of the eIF4F initiation complex .
Art. -Nr.: HY-148443
CAS. Nr.: 1402931-71-8
Reinheit:  99.71%
Forschungsgebiete:  

Cancer

eIF4A3-IN-9 is a Rocaglate analog. eIF4A3-IN-9 interferes with the assembly of the eIF4F translation complex, with EC50 values of 29 and 450 nM against myc-LUC and tub-LUC, respectively. eIF4A3-IN-9 can be used for the research of tumor pathogenesis .
Art. -Nr.: HY-148446
CAS. Nr.: 1402931-76-3
Forschungsgebiete:  

Cancer

eIF4A3-IN-12 (compound 62) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-12 interferes the assembling of eIF4F translation complex with EC50s of 4, 70 and 5 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-12 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-148452
CAS. Nr.: 1402931-84-3
Reinheit:  98.82%
Forschungsgebiete:  

Cancer

eIF4A3-IN-18 (compound 74) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-18 interferes the assembling of eIF4F translation complex with EC50 values of 0.8, 35 and 2 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-18 also has cytotoxicity to RMPI-8226 cells with an LC50 of 0.06 nM. eIF4A3-IN-18 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-148444
CAS. Nr.: 1402931-72-9
Reinheit:  97.87%
Forschungsgebiete:  

Cancer

eIF4A3-IN-10 (compound 58) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-10 interferes the assembling of eIF4F translation complex with EC50s of 35 and 100 nM for myc-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-10 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-148451
CAS. Nr.: 1402931-75-2
Forschungsgebiete:  

Cancer

eIF4A3-IN-17 (compound 61) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-17 interferes the assembling of eIF4F translation complex with EC50s of 0.9, 15 and 1.8 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-17 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-RS04274
Forschungsgebiete:  

Others

EIF4E Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Art. -Nr.: HY-148445
CAS. Nr.: 1402931-70-7
Forschungsgebiete:  

Cancer

eIF4A3-IN-11 (compound 56) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-11 interferes the assembling of eIF4F translation complex with EC50s of 0.2, 4 and 0.3 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-11 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-RS04281
Forschungsgebiete:  

Others

EIF4G1 Human Pre-designed siRNA Set A contains three designed siRNAs for EIF4G1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Art. -Nr.: HY-164524
CAS. Nr.: 1321827-45-5
Forschungsgebiete:  

Cancer

SBI-0640726 is an eIF4G1 inhibitor with antiproliferative activity in melanoma. SBI-0640726 disrupts the eIF4F translation initiation complex by inhibiting AKT and NF-kB signaling pathways. SBI-0640726 inhibits the growth of NRAS and BRAF mutant melanoma in vitro .
Art. -Nr.: HY-148449
CAS. Nr.: 1402931-66-1
Forschungsgebiete:  

Cancer

eIF4A3-IN-15 (compound 52) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-15 interferes the assembling of eIF4F translation complex with EC50s of 11, 700 and 120 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-15 can be used for the research of human cancer pathogenesis .
Art. -Nr.: HY-182704
CAS. Nr.: 832680-32-7
Synonyms: SBI-1275844
Forschungsgebiete:  

Infection

SBI-5844 (SBI-1275844) is a eIF4F complex inhibitor and antiviral agent. SBI-5844 disrupts the assembly of the eIF4F complex and blocks the interaction between eIF4E and eIF4G. SBI-5844 inhibits the synthesis of HCoV-OC43 nucleocapsid protein and reduces the levels of HCoV-OC43 RNA and total protein. SBI-5844 can be used in studies related to human coronavirus OC43 (HCoV-OC43) infection .
Art. -Nr.: HY-P85133
Synonyms: eIF4E; eIF4EL1; eIF4F; Eukaryotic translation initiation factor 4E; eIF-4E; eIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC, ELISA

Reactivity:  

Human

Art. -Nr.: HY-P86175
Synonyms: eIF4E; eIF4EL1; eIF4F; Eukaryotic translation initiation factor 4E; eIF-4E; eIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

Art. -Nr.: HY-P70152
Reinheit:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: rHuEukaryotic translation initiation factor 4E/eIF4E; Eukaryotic translation initiation factor 4E; eIF-4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein; eIF4E; eIF4EL1; eIF4F
Species:  
Source: